Date |
|
Dec 26, 2013 |
CEL-SCI Corporation Announces Closing of Public Offering and Exercise of Over-Allotment Option for Aggregate Gross Proceeds of $3.3 Million |
Dec 19, 2013 |
CEL-SCI Corporation Prices $3.0 Million Public Offering of Common Stock and Warrants |
Dec 18, 2013 |
CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants |
Dec 12, 2013 |
CEL-SCI Corporation Releases Letter to Shareholders |
Dec 9, 2013 |
CEL-SCI Warrants Approved for Trading under the Ticker Symbol “CSCIW” |
Dec 5, 2013 |
CEL-SCI Receives Government Approval in Bosnia and Herzegovina to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer |
Nov 20, 2013 |
CEL-SCI Conducts Meeting of North American Clinical Centers to Support Success of Its Phase III Cancer Trial with Multikine |
Nov 12, 2013 |
CEL-SCI Receives Croatian Government Approval to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer |
Nov 5, 2013 |
CEL-SCI Corporation Announces IDMC Conclusions From Interim Review of Phase III Head and Neck Cancer Trial Data |
Oct 31, 2013 |
CEL-SCI Announces Initiation of Arbitration against Former Clinical Research Organization |